PHLDA2 and cancer: To examine whether expression of PHLDA2 enhances sensitivity of NSCLC cells to targeted agents, MTS cell proliferation assay was used to assess the role of PHLDA2 in lapatinib sensitivity of ErbB2-positive cancer cells.